GW501516 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-04-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516; GW-1516; endurobol | GW501516 is the research code |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator |
| Molecular formula | C21H18F3NO3S2 | Established chemical formula |
| Molar mass | 453.5 g/mol | Calculated from the formula |
| Regulatory status | Prohibited in sport; not approved as medicine | Status varies by country |
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
=== Lawsuits === From 2019 to 2024, Maria Francesca Gioia, a former medical student acting as a pro se plaintiff, filed nine product liability lawsuits against Janssen Pharmaceuticals and related parties. She alleged that taking Invega Sustenna (paliperidone palmitate) caused her memory loss, hypothyroidism, Horner's syndrome, nerve damage, motor tremors, vocal tics, confusion, loss of taste and sensation, post-traumatic stress disorder, and metabolic syndrome (including hypertension, diabetes, and stroke), which ended her career as a primary care physician. All nine lawsuits were dismissed on procedural grounds: Gioia I–II for failure to state a claim, Gioia III for failure to prosecute, and Gioia IV–V for lack of subject matter jurisdiction. The court also noted that the side effects she alleged were already listed on Invega's FDA-approved warning label. In June 2020, a Florida lawsuit was filed on behalf of Lilith Geohaghan, an 82-year-old assisted living resident with Lewy body dementia, against the assisted living facility and several healthcare providers. The complaint alleged that despite her family's explicit instructions to the contrary, she was administered multiple large doses of Invega Sustenna in late 2018. The lawsuit claims that the injections led to a rapid decline in her health, resulting in nearly a dozen falls and two hospitalizations within just over a month. Her treating physicians subsequently diagnosed her with toxic encephalopathy, directly attributing the condition to the Invega Sustenna injections.
Upon release, the album was met with widespread acclaim from critics. According to the review aggregator Metacritic, Let God Sort Em Out received "universal acclaim" based on a weighted average score of 83 out of 100 from eleven critic scores. Alexis Petridis of The Guardian gave the album a perfect score and called it "as strong a restatement of Clipse's skills and power as you could wish for". The lyrical versatility was praised ("Great lines abound, from the chilling to the laugh-out-loud"), as were the duo's chemistry; the guest appearances, which were said to have "step[ped] up" without stealing the show; and the "inspired" production. He concluded by declaring it one of the best albums of the year. Tom Breihan of Stereogum shared similar sentiments when reviewing the album for the publication's Premature Evaluation column, commenting on its "minimal, stabbing intensity" that he likened to Clipse's second album, Hell Hath No Fury (2006). Lyrically, he also praised the duo's chemistry with the featured guests—Stove God Cooks and Ab-Liva in particular—and Malice's presence, which "still has the gravitational force of a black hole". Niall Smith of Clash gave the album a nine out of ten and described the lyrics as a balance between the duo's old style and introspection on "maturity, perspective[,] and loss". Smith felt that the album's most impressive aspect was the guest appearances; although he felt some of Williams's choruses were "shakier moments", they were mostly redeemed by Clipse's "synergy".
ATP hydrolysis by AAA ATPases is proposed to involve nucleophilic attack on the ATP gamma-phosphate by an activated water molecule, leading to movement of the N-terminal and C-terminal AAA subdomains relative to each other. This movement allows the exertion of mechanical force, amplified by other ATPase domains within the same oligomeric structure. The additional domains in the protein allow for regulation or direction of the force towards different goals.
Orthologs of the human TBR1 gene have been identified in chimpanzee, dog, cow, rat, mouse, and zebrafish. In mice, TBR1 has been found to function in development of the brain, eye, immune system, mesoderm, and placenta. It is also involved in glutamatergic neuronal differentiation in the developing mouse brain. It was discovered that Tbr-1 is expressed by postmitotic cortical neurons in mice and in humans. One target gene of TBR1 in the mouse brain is RELN or Reelin. Tbr-1 mutant mice have been found to have reduced RELN expression, resulting in improper neuronal migration, particularly in Cajal-Retzius cells of the marginal zone. Other studies in mice have found that TBR1 is a repressor or Fezf2. It has also been found to negatively regulate corticospinal tract formation.
Multiple animal studies have investigated the biological activity of D-ribose-L-cysteine in models of oxidative stress and metabolic injury. These studies have reported that D-ribose-L-cysteine supplementation increases intracellular and tissue glutathione levels, improves antioxidant enzyme activity, and reduces markers of oxidative damage in rodents. In several experimental models, D-ribose-L-cysteine demonstrated equal or greater glutathione-enhancing effects compared with N-acetylcysteine, though these findings are limited to preclinical settings. Cell culture studies have reported that D-ribose-L-cysteine increases glutathione levels and modulates oxidative stress responses in normal cell lines exposed to cytotoxic agents.
Sources: en.wikipedia.org
The strontium radioisotopes are very important, as strontium is a calcium mimic which is incorporated in bone growth and therefore has a great ability to harm humans. On the other hand, this also allows 89Sr to be used in the open source radiotherapy of bone tumors. This tends to be used in palliative care to reduce the pain due to secondary tumors in the bones. Strontium-90 is a strong beta emitter with a half-life of 28.8 years. Its fission product yield decreases as the mass of the fissile nuclide increases - fission of 233U produces more 90Sr than fission of 239Pu with fission of 235U in the middle. A map of 90Sr contamination around Chernobyl has been published by the IAEA. Due to its very small neutron absorption cross section, strontium-90 is poorly suited for thermal neutron induced nuclear transmutation as a way of disposing of it. Strontium-90 has been used in radioisotope thermoelectric generators (RTGs) in the past because of its relatively high power density (0.95 Wthermal/g for the metal, 0.46 Wthermal/g for the commonly used inert perovskite form strontium titanate) and because it is easily extracted from spent fuel (both native strontium metal and strontium oxide react with water by forming soluble strontium hydroxide). However, the increased availability of renewable energy for off-grid applications formerly served by RTGs as well as concern about orphan sources has led to a nigh-total abandonment of 90Sr in RTGs.
Further LLM developments during what has been called an "AI boom" include: local or open source versions of LLaMA which was leaked in March, news outlets report on GPT4-based Auto-GPT that given natural language commands uses the Internet and other tools in attempts to understand and achieve its tasks with unclear or so-far little practicality, a systematic evaluation of answers from four "generative search engines" suggests their outputs "appear informative, but frequently contain unsupported statements and inaccurate citations", a multi-modal open source tool for understanding and generating speech, a data scientist argues that "researchers need to collaborate to develop open-source LLMs that are transparent" and independent, Stability AI launches an open source LLM. On 12 April, researchers demonstrate an 'AI scientist' that can create of models of natural phenomena from knowledge axioms and experimental data, showing the software can rediscover physical laws using logical reasoning and few data points. Promising results of therapeutic candidates are reported: a review suggests daily vitamin D3 may reduce cancer mortality by around 12% (31 Mar), review of experimental phototherapies against dementia cognitive decline (5 Apr), mice-tested L.
The Ghana Prisons Service and the sub-division Borstal Institute for Juveniles administers incarceration. The new sustainable development goals adopted by the United Nations call for the international community to come together to promote the rule of law; support equal access to justice for all; reduce corruption; and develop effective, accountable, and transparent institutions at all levels. Ghana is used as a key narcotics industry transshipment point by traffickers, usually from South America and some from other African nations. In 2013, the UN chief of the Office on Drugs and Crime stated that "West Africa is completely weak in terms of border control and the big drug cartels from Colombia and Latin America have chosen Africa as a way to reach Europe." The social context within which narcotic trafficking, storage, transportation, and repacking systems exist in Ghana and the state's location along the Gulf of Guinea makes Ghana a more attractive country for the narcotics business. The Narcotics Control Board has impounded container ships at the Sekondi Naval Base in the Takoradi Harbour. These ships were carrying thousands of kilograms of cocaine, with a street value running into billions of Ghana cedis. Drug seizures saw a decline in 2011. Drug cartels are using new methods in narcotics production and narcotics exportation, to avoid Ghanaian security agencies. Underdeveloped institutions, porous open borders, and the existence of established smuggling organisations contribute to Ghana's position in the narcotics industry.
Most hematology analyzers provide a five-part differential, enumerating neutrophils, lymphocytes, monocytes, eosinophils and basophils. Some instruments can also count immature granulocytes and nucleated red blood cells. If a six-part differential is provided, the IG or immature granulocyte category consists of promyelocytes, myelocytes and metamyelocytes. Hematology analyzers measure various properties of white blood cells, such as impedance, light scattering parameters, and staining reactions. This data is analyzed and plotted on a scattergram, forming distinct clusters which correspond to white blood cell types. The analyzer counts many more cells than are counted in a manual differential, resulting in improved precision. If abnormal features or cell populations that the analyzer cannot identify are present, the instrument can flag the results for manual blood smear review.
=== Deaths === Combined consumption of U-47700 with fentanyl and flubromazepam caused one fatality each in Belgium and Germany, respectively. One death was reported in Ireland and another one in Italy. 17 opioid overdoses and several deaths in the United States had initially been associated with U-47700 in April 2016. As of September 2016 at least 15 fatalities were confirmed. By December 2017, at least 46 fatalities had been associated with the use of U-47700. U-47700 was found in combination with fentanyl during the autopsy of the American artist Prince in 2016.
Sources: en.wikipedia.org
The Global Cold Chain Alliance (GCCA) is an international trade association representing industries engaged in temperature-controlled warehousing, logistics and transportation. The alliance is headquarter in Arlington, Virginia in the United States. In 2007 the Global Cold Chain Alliance was formed through the merger of the International Association of Refrigerated Warehouses (IARW) and International Refrigerated Transportation Association (IRTA), when leaders of both organisations realised that global supply chain depends on transportation and warehousing working closely together. The World Food Logistics Organization (WFLO) would later join as a core partner of the alliance as well as the Controlled Environment Building Association (CEBA). The GCCA serves as the central coordinating body for these associations, promoting best practices, advocacy, and industry development worldwide.
It was around the same time, with the work of Jean-Baptiste Bécœur in particular, that taxidermy became a more serious practice. Louis Dufresne, a taxidermist at the Muséum National d'Histoire Naturelle in France, rediscovered Bécœur's taxidermy process using arsenical soap and made it known through an article in the Nouveau dictionnaire d'histoire naturelle (1803–1804). This technique enabled the museum to build an immense collection of taxidermy birds. In the 19th century, some hunters took their trophies to upholstery shops, where the upholsterers would sew up the animal skins and stuff them with rags and cotton. The term "stuffing" or a "stuffed animal" evolved from this crude form of taxidermy. Professional taxidermists prefer the term "mounting" to "stuffing". More sophisticated cotton-wrapped wire bodies supporting sewn-on cured skins soon followed. Dufresne's methods spread to England in the early 19th century, where updated and non-toxic methods of preservation were developed by some of the leading naturalists of the day, including Rowland Ward and Montague Brown. Ward established one of the earliest taxidermy firms, Rowland Ward Ltd. of Piccadilly. However, the art of taxidermy remained relatively undeveloped, and the specimens remained stiff and unconvincing. Between 1887 and 1894, many naturalist scientists from all over the world went to Costa Rica to research its bird wildlife. At that time, Costa Rica had unique bird species not found in other parts of the world.
A large body of evidence shows either directly or indirectly that small ions (from small molecules) are liberated into the gas phase through the ion evaporation mechanism, while larger ions (from folded proteins for instance) form by charged residue mechanism. A third model invoking combined charged residue-field emission has been proposed. Another model called chain ejection model (CEM) is proposed for disordered polymers (unfolded proteins). The ions observed by mass spectrometry may be quasimolecular ions created by the addition of a hydrogen cation and denoted [M + H]+, or of another cation such as sodium ion, [M + Na]+, or the removal of a hydrogen nucleus, [M − H]−. Multiply charged ions such as [M + nH]n+ are often observed. For large macromolecules, there can be many charge states, resulting in a characteristic charge state envelope. All these are even-electron ion species: electrons (alone) are not added or removed, unlike in some other ionization sources. The analytes are sometimes involved in electrochemical processes, leading to shifts of the corresponding peaks in the mass spectrum. This effect is demonstrated in the direct ionization of noble metals such as copper, silver and gold using electrospray. The efficiency of generating the gas phase ions for small molecules in ESI varies depending on the compound structure, the solvent used and instrumental parameters. The differences in ionization efficiency reach more than 1 million times.
but that still shouldn't hurt someone taking legalized performance enhancing substances to try and absolutely RIP it out there in competition." Financial Times said the same month "A year on, with just one athlete publicly signed on to the project and no concrete plans for either a venue or a date, the project looks increasingly like a weird thought experiment, despite its high-profile backers. For D'Souza, the second Trump presidency could be what the Enhanced Games needs to get off the ground." The Times said in May 2025 "The Enhanced Games may be divisive, even dystopian to some. As far as D'Souza is concerned, they are the future — and the starting pistol is about to fire." Time listed D'Souza and Angermayer among the "Most Influential People in Health of 2025". The Economist said that the Games align with a growing human enhancement industry, aiming to improve strength, intelligence, and longevity.
The onset of heroin's effects depends upon the route of administration. Smoking is the fastest route of drug administration, although intravenous injection results in a quicker rise in blood concentration. These are followed by suppository (anal or vaginal insertion), insufflation (snorting), and ingestion (swallowing). A 2002 study suggests that a fast onset of action increases the reinforcing effects of addictive drugs. Ingestion does not produce a rush as a forerunner to the high experienced with the use of heroin, which is most pronounced with intravenous use. While the onset of the rush induced by injection can occur in as little as a few seconds, the oral route of administration requires approximately half an hour before the high sets in. Thus, with both higher the dosage of heroin used and faster the route of administration used, the higher the potential risk for psychological dependence/addiction. Large doses of heroin can cause fatal respiratory depression and the drug has been used for the purposes of suicide and homicide. The serial killer Harold Shipman used diamorphine on his victims, and the subsequent Shipman Inquiry led to a tightening of the regulations surrounding the storage, prescribing and destruction of controlled drugs in the UK. Because significant tolerance to respiratory depression develops quickly with continued use and is lost just as quickly during withdrawal, it is often difficult to determine whether a heroin lethal overdose was accidental, suicide or homicide.
Sources: en.wikipedia.org
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.
No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.
Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.
Cardarine targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not bind the androgen receptor in the way SARMs do.